Verana Health

What Verana Health does

Verana Health is a digital health company that builds and operates a curated real-world data (RWD) and real-world evidence (RWE) platform for the life sciences industry. The company's VeraQ Population Health Data Engine uses AI, machine learning, natural language processing, and large language model-based techniques, combined with expert clinical review, to transform unstructured electronic health record (EHR) data into regulatory-grade research-ready datasets. Verana holds exclusive data and analytics partnerships with the American Academy of Ophthalmology (IRIS Registry, 87+ million patients) and the American Urological Association (AQUA Registry), and following its January 2026 merger with COTA Healthcare, also has access to 30+ Academic Medical Centers and 10+ million oncology patients, giving the combined entity visibility into over 95 million de-identified patients across more than 20,000 contributing clinicians.

The company's product surface spans a Qdata suite of therapeutic-specific curated datasets across ophthalmology, oncology, neurology, and urology; SaaS applications including Site Explorer for clinical trial site selection, Verana Trial Connect for patient enrollment, Quality Measures Dashboard (with Agent Claire AI agent) for MIPS reporting, and Qdata Explorer for self-serve data discovery; and project-based real-world evidence research services for pharmaceutical and biotechnology clients. Verana serves life sciences companies (17 of the top 20 global biopharmaceutical companies), Contract Research Organizations, medical affairs and HEOR teams, commercial teams, and clinicians participating in AAO and AUA registries, with named customers including Genentech, Ocular Therapeutix, Nanoscope Therapeutics, and Sight Sciences.

Revenue is generated through SaaS subscriptions (Site Explorer, Verana Trial Connect, Quality Measures Dashboard), Data-as-a-Service licensing for Qdata modules, and project-based research services, sold primarily through direct enterprise field sales with custom multi-year contracts. Distribution is augmented by medical society partnerships that provide clinician-side access and by CRO and technology partnerships (Komodo Health, HealthVerity, Guardant Health, Databricks, AWS Data Exchange) that extend data ecosystem reach. The company is headquartered in San Francisco with offices in New York and Knoxville, and is backed by Johnson & Johnson Innovation – JJDC, Novo Growth, GV, Casdin Capital, Brook Byers, Merck Global Health Innovation Fund, THVC, and Breyer Capital.

Name

Verana Health

Legal name

Verana Health, Inc.

Website

https://veranahealth.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Verana Health is a digital health company that curates real-world clinical data from exclusive medical society registries and EHRs using AI and LLMs, serving pharmaceutical and biotech companies with regulatory-grade evidence, clinical trial tools, and therapeutic-specific datasets across ophthalmology, oncology, neurology, and urology.

Ownership category

akta.pro rank

Product category

Healthcare Real-World Evidence and Clinical Data Analytics

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Software Publishers (5132), Scientific Research and Development Services (5417), Custom Computer Programming Services (541511)

SIC

Services-Computer Processing & Data Preparation (7374), Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK), Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL)

Keywords

• Real-world evidence solutions
• Clinical trial analytics
• Medical registry data
• Healthcare data curation
• Regulatory-grade datasets

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS Subscriptions: Verana Health offers subscription-based SaaS applications including Site Explorer, Verana Trial Connect, and Quality Measures Dashboard. These applications are available to qualifying members of medical society registries and life sciences organizations on annual or multi-year contract terms.
2. Data-as-a-Service (DaaS): Access to curated therapeutic-specific real-world datasets (Qdata) for research and analysis purposes. Life sciences companies license access to these datasets for clinical development, HEOR, and commercialization insights.
3. Project-Based Research Services: Custom real-world evidence studies, clinical trial emulation, and analysis projects conducted for pharmaceutical and biotech clients seeking specific insights from curated datasets.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Verana Health operates a cloud-based healthcare data platform that curates, structures, and analyzes real-world data (RWD) from electronic health records and exclusive medical society registries (AAO IRIS Registry, AUA AQUA Registry). It delivers therapeutic-area-specific curated datasets (Qdata) covering ophthalmology, urology, oncology, and neurology, alongside subscription-based SaaS applications for clinical trial site selection (Site Explorer), patient enrollment (Verana Trial Connect), and MIPS quality reporting (Quality Measures Dashboard with Agent Claire). The platform also provides project-based real-world evidence (RWE) research services to pharmaceutical, biotechnology, and CRO clients.

Product overview

Verana Health is a digital health company offering a platform-plus-modules architecture centered on its VeraQ Population Health Data Engine and Qdata product suite. The core platform utilizes AI and machine learning to curate and transform data from exclusive partnerships with medical societies (American Academy of Ophthalmology IRIS Registry and American Urological Association AQUA Registry) into regulatory-grade real-world evidence. The Qdata modules provide therapeutic-specific curated datasets across ophthalmology, neurology, urology, and oncology specialties. The company complements its data products with SaaS applications including Site Explorer for clinical trial site selection, Verana Trial Connect for patient enrollment, and Quality Measures Dashboard for MIPS reporting. Following its merger with COTA Healthcare, the combined entity serves 17 of the top 20 global biopharma companies with access to over 95 million patients and more than 20,000 clinicians.

Differentiator

Problem solved

Functional benefit

Brands

• VeraQ: Population health data engine used for curating and processing real-world data at scale
• Qdata
• IRIS Registry
• AQUA Registry
• Site Explorer
• Verana Trial Connect
• Quality Measures Dashboard
• Agent Claire

Products and services

• Qdata Flaghip suite of curated real-world data modules providing research-ready datasets across multiple therapeutic areas including ophthalmology, neurology, urology, and oncology. Each Qdata module aggregates structured and unstructured EHR data using AI and LLM-based curation techniques to deliver longitudinal patient insights for clinical research and drug development by life sciences companies.
• Ophthalmology Qdata Curated real-world data module for ophthalmic conditions sourced from the AAO IRIS Registry (87+ million patients), providing comprehensive insights into eye diseases and treatments for life sciences research.
• Urology Qdata Curated real-world data module for urological conditions sourced from the AUA AQUA Registry, covering bladder cancer, prostate cancer, and benign prostatic hyperplasia for life sciences research.
• Oncology Qdata Curated real-world oncology data module providing insights into cancer treatment patterns, patient outcomes, and clinical research, sourced from the COTA Healthcare merger and academic medical centers.
• Neurology Qdata Curated real-world data module for neurological conditions including multiple sclerosis, Parkinson's disease, and spinal muscular atrophy, providing longitudinal patient journey insights for life sciences research.
• Site Explorer Subscription-based clinical trial site selection tool that enables trial sponsors and CROs to identify study sites with specific patient populations, model protocols, reduce recruitment timelines, and build enrollment cohorts reflective of subpopulation demographics.
• Verana Trial Connect Clinical trial patient enrollment application providing end-to-end support for patient recruitment, enabling monitoring of deidentified screening activity across sites in real time for sponsors and CROs.
• Quality Measures Dashboard Dashboard application for clinicians participating in MIPS for Medicare reimbursement, featuring AI agent Agent Claire to assist with reporting, compliance, and operational performance.
• Qdata Explorer Interactive self-service tool for exploring Qdata modules and their contents, enabling researchers to understand dataset variables and patient populations.
• Anti-VEGF Market Tracker Real-world data product tracking anti-VEGF treatment patterns and market dynamics for ophthalmic conditions including wet AMD and diabetic macular edema for life sciences customers.
• Practice Insights Member value tool providing clinicians with insights into their practice patterns and patient outcomes based on registry data from the AAO IRIS and AUA AQUA registries.
• Clinical Research Solutions End-to-end clinical research services including trial design, protocol optimization and site selection, patient recruitment, and prospective evidence generation (PEG) for life sciences customers.
• RWE Studies Real-world evidence study services including patient segmentation, safety studies, natural history of disease studies, comparative effectiveness, treatment patterns and outcomes, and healthcare resource utilization cost analysis.
• Market Insights Market intelligence services including market tracking, brand switching analysis, and prescriber mapping for life sciences commercial teams.

Quantifiable outcome

• Access to 95+ million de-identified patients across 20,000+ clinicians
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability10 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core, major, strategic and technology.

• Guardant HealthcoreStrategic or Co-development Partner · 24 March 2026Partnership to combine Verana Health's regulatory-grade EHR curated datasets with Guardant's clinicogenomic testing data for precision medicine research. Enables biopharma researchers to study correlations between molecular biomarkers, treatment decisions, and clinical outcomes across cancer types including bladder, lung, breast, and colorectal cancers.
• COTA HealthcarecoreStrategic or Co-development Partner · 8 January 2026Merger between Verana Health and COTA Healthcare in January 2026, supported by a $52 million equity investment. The combined entity expanded access to over 30 Academic Medical Centers and 10+ million oncology patients, enabling service to 17 of the top 20 global biopharma companies.
• American Academy of Ophthalmology (AAO) - IRIS RegistrycoreStrategic or Co-development Partner · 8 January 2024Exclusive data and analytics partnership making Verana Health the exclusive partner for the IRIS Registry (Intelligent Research in Sight), the world's largest specialty clinical data registry in ophthalmology with data on over 87 million patients.
• American Urological Association (AUA) - AQUA RegistrycoreStrategic or Co-development Partner · 8 January 2024Exclusive data and analytics partnership making Verana Health the exclusive partner for the AQUA Registry (AUA Quality Registry), providing access to urological patient data supporting research and clinical insights.
• American Academy of Neurology (AAN)majorStrategic or Co-development PartnerPartnership for neurology data initiatives including Qdata MS (Multiple Sclerosis) research platform providing curated real-world data for neurology research.
• Komodo HealthstrategicTechnology or IntegrationPartnership to give clinical researchers deeper insight into real-world patient journeys by combining Verana Health's curated registry data with Komodo's healthcare data ecosystem.
• HealthVeritystrategicTechnology or IntegrationPartnership to advance the use of real-world evidence in research through HealthVerity's data connectivity and patient tokenization capabilities.
• Foundation Fighting BlindnessstrategicStrategic or Co-development PartnerPartnership to integrate genetic testing data into real-world evidence research for inherited retinal diseases, enhancing clinical trial capabilities for rare eye conditions.
• DatabrickstechnologyTechnology or IntegrationTechnology partnership using Databricks Lakehouse platform to democratize data and deploy AI for medical innovation, supporting Verana Health's data processing infrastructure.
• AWS (Amazon Web Services)technologyTechnology or IntegrationCloud partnership enabling cloud-based access to Verana Health's curated, de-identified real-world data through AWS Data Exchange.
• Tufts Center for the Study of Drug Development (CSDD)strategicStrategic or Co-development PartnerResearch sponsorship of Tufts CSDD studies on RWD/RWE value in clinical trials, providing industry insights and validating market positioning.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Flatiron Health: Oncology-focused real-world data and EHR curation company, acquired by Roche for $1.9B. Competes directly with Verana's Oncology Qdata and COTA-derived offerings for biopharma RWE, clinical trial, and commercial analytics engagements.
• ConcertAI: Oncology RWD and AI-driven evidence generation platform serving biopharma, with emphasis on clinical trial optimization and real-world evidence. Overlaps with Verana/COTA in oncology data licensing, synthetic control arms, and patient journey analytics.
• Tempus Labs: AI-enabled precision medicine company combining genomic sequencing, clinical data, and RWD for biopharma and providers. Overlaps with Verana in oncology RWD, biomarker-correlated real-world evidence, and AI-driven clinical trial support.
• Komodo Health: Healthcare data and analytics platform providing patient-level insights across the U.S. healthcare system for life sciences and payer clients. Functions as both a partner (announced collaboration with Verana) and competitor for RWD-driven trial design and commercial analytics.
• Syapse: Oncology real-world evidence platform aggregating de-identified patient data from a network of health systems for biopharma research. Direct overlap with Verana/COTA in oncology RWD licensing and clinical trial support.

Broad incumbents

• IQVIA: Largest global CRO and healthcare data company with extensive RWD assets, EDC/CTMS platforms, and commercial analytics. Competes with Verana across the full real-world evidence stack while serving overlapping top-20 biopharma customers with broader portfolios.
• Medidata (Dassault Systèmes): Industry-standard clinical trial technology platform (EDC, CTMS, eCOA) with growing RWD/RWE capabilities following the Acorn AI launch. Competes with Verana's Site Explorer and Verana Trial Connect for trial design, site selection, and patient recruitment.

Others

• Optum (UnitedHealth Group): Optum serves as the broad incumbent; revising to BROAD_INCUMBENT. Massive healthcare data, analytics, and research services division of UnitedHealth, combining claims, EHR, and clinical data for life sciences. Competes with Verana on commercial analytics, HEOR, and increasingly on real-world evidence generation.
• HealthVerity: Healthcare data connectivity and patient tokenization platform enabling privacy-protected data linkage across sources. Functions as both an enabling partner (announced collaboration with Verana) and an adjacent competitor in the RWD ecosystem.
• Datavant: Healthcare data connectivity and de-identification infrastructure provider enabling privacy-preserving data exchange across the ecosystem. Acts as a complementary/competing data linkage layer to Verana's proprietary VeraQ curation engine.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@veranahealth
• LinkedInlinkedin.com/company/verana-health
• Xx.com/veranahealth
• Facebookfacebook.com/VeranaHealth

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Verana Health